86 related articles for article (PubMed ID: 9238617)
1. Recombinant tissue plasminogen activator to declot dialysis fistulas.
Boobes Y; al Hassan H; Neglen P; Obeid K; Denour N
J Nephrol; 1997; 10(2):107-10. PubMed ID: 9238617
[TBL] [Abstract][Full Text] [Related]
2. Recombinant tissue plasminogen activator (rt-PA) as first-line therapy for declotting of haemodialysis access.
Andriani M; Drago G; Bernardi AM; Da Porto A; De Luca M; Riegler P; Biasia F; Pinzani A
Nephrol Dial Transplant; 1995; 10(9):1714-9. PubMed ID: 8559494
[TBL] [Abstract][Full Text] [Related]
3. The use of tissue plasminogen activator to declot arteriovenous accesses in hemodialysis patients.
Ahmed A; Shapiro WB; Porush JG
Am J Kidney Dis; 1993 Jan; 21(1):38-43. PubMed ID: 8418624
[TBL] [Abstract][Full Text] [Related]
4. [In situ fibrinolysis of acute arteriovenous shunt obstructions during hemodialysis].
Jahn C; Lebras Y; Mutter D; Petitjean P; Roy C; Schnitzler B; Dimitrov Y
Nephrologie; 1994; 15(2):145-50. PubMed ID: 8047201
[TBL] [Abstract][Full Text] [Related]
5. [Treatment trials of plasminogen activator (rt-PA) in central vein thrombosis of the retina].
Reim M; Bertram B; Wolf S
Klin Wochenschr; 1988; 66 Suppl 12():143-9. PubMed ID: 3126343
[TBL] [Abstract][Full Text] [Related]
6. Mechanical thrombectomy of occluded hemodialysis native fistulas and grafts using a hydrodynamic thrombectomy catheter: preliminary experience.
Sahni V; Kaniyur S; Malhotra A; Fan S; Blakeney C; Fotheringham T; Sobeh M; Matson M
Cardiovasc Intervent Radiol; 2005; 28(6):714-21. PubMed ID: 16059764
[TBL] [Abstract][Full Text] [Related]
7. Benefits of Long Versus Short Thrombolysis Times for Acutely Thrombosed Hemodialysis Native Fistulas.
Regus S; Lang W; Heinz M; Uder M; Schmid A
Vasc Endovascular Surg; 2017 Jul; 51(5):233-239. PubMed ID: 28639916
[TBL] [Abstract][Full Text] [Related]
8. [Thrombotic complications of arterio-venous fistulas in chronically hemodialysed patients].
Kawecka A; Prajs J; Lipiński J; Białko M
Wiad Lek; 1997; 50 Suppl 1 Pt 2():60-4. PubMed ID: 9424928
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis with alteplase: a non-invasive treatment for occluded arteriovenous fistulas and grafts.
Tseke P; Kalyveza E; Politis E; Giapraka N; Andriopoulos C; Balitsari A; Papatzikos L; Stavgianoudakis G
Artif Organs; 2011 Jan; 35(1):58-62. PubMed ID: 20626738
[TBL] [Abstract][Full Text] [Related]
10. [Thrombolytic therapy of deep venous thrombosis with rt-PA].
Zimmermann R; Horn A; Harenberg J; Diehm C; Müller-Bühl U; Kübler W
Klin Wochenschr; 1988; 66 Suppl 12():137-42. PubMed ID: 3126342
[TBL] [Abstract][Full Text] [Related]
11. Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft occlusions.
Graor RA; Risius B; Lucas FV; Young JR; Ruschhaupt WF; Beven EG; Grossbard EB
Circulation; 1986 Sep; 74(3 Pt 2):I15-20. PubMed ID: 3091288
[TBL] [Abstract][Full Text] [Related]
12. Local thrombolysis with recombinant tissue plasminogen activator for thrombosed vascular access in hemodialysis patients.
Vlassopoulos D; Logothetis E; Arvanitis D; Noussias C; Magana P; Katopodis K; Hadjiconstantinou V
Clin Nephrol; 1996 Jul; 46(1):77-8. PubMed ID: 8832159
[No Abstract] [Full Text] [Related]
13. Three-dimensional contrast-enhanced magnetic resonance angiography (3-D CE-MRA) in the evaluation of hemodialysis access complications, and the condition of central veins in patients who are candidates for hemodialysis access.
Paksoy Y; Gormus N; Tercan MA
J Nephrol; 2004; 17(1):57-65. PubMed ID: 15151260
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
[TBL] [Abstract][Full Text] [Related]
15. The management and outcome of occluded haemodialysis access: a retrospective audit.
Yehia M; McDonald M; Walker R
N Z Med J; 2002 Nov; 115(1166):U258. PubMed ID: 12552276
[TBL] [Abstract][Full Text] [Related]
16. A preliminary investigation of balloon angioplasty versus surgical treatment of thrombosed dialysis access grafts.
McCutcheon B; Weatherford D; Maxwell G; Hamann MS; Stiles A
Am Surg; 2003 Aug; 69(8):663-7; discussion 668. PubMed ID: 12953823
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator as a hemodialysis catheter locking solution.
McGill RL; Spero JA; Sysak JC; Sandroni SE; Marcus RJ
Hemodial Int; 2008 Jul; 12(3):348-51. PubMed ID: 18638092
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous therapy to maintain dialysis access successfully prolongs functional duration after primary failure.
Bakken AM; Galaria II; Agerstrand C; Saad WE; Surowiec SM; Singh MJ; Rhodes JM; Lee D; Patel NC; Illig KA; Waldman DL; Davies MG
Ann Vasc Surg; 2007 Jul; 21(4):474-80. PubMed ID: 17499964
[TBL] [Abstract][Full Text] [Related]
19. Creating arteriovenous fistulas in 132 consecutive patients: exploiting the proximal radial artery arteriovenous fistula: reliable, safe, and simple forearm and upper arm hemodialysis access.
Jennings WC
Arch Surg; 2006 Jan; 141(1):27-32; discussion 32. PubMed ID: 16415408
[TBL] [Abstract][Full Text] [Related]
20. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
Quarello F; Forneris G; Borca M; Pozzato M
J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
